One-year treatment retention after a nationwide nonmedical switch from originator to biosimilar etanercept in 2061 patients with inflammatory arthritis followed in the DANBIO registry

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY(2018)

引用 22|浏览30
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要